Chen, R., Frankel, P., Popplewell, L., Siddiqi, T., Ruel, N., Rotter, A., . . . Kirschbaum, M. (2015). A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma. Haematologica.
Stile di citazione ChicagoChen, Robert, et al. "A Phase II Study of Vorinostat and Rituximab for Treatment of Newly Diagnosed and Relapsed/refractory Indolent Non-Hodgkin Lymphoma." Haematologica 2015.
Citazione MLAChen, Robert, et al. "A Phase II Study of Vorinostat and Rituximab for Treatment of Newly Diagnosed and Relapsed/refractory Indolent Non-Hodgkin Lymphoma." Haematologica 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.